Effect of Large Neutral Amino Acids in Adults With Classical Phenylketonuria

Recruiting N/A Interventional Study
Brain Diseases Brain Diseases, Metabolic Brain Diseases, Metabolic, Inborn Genetic Diseases, Inborn Metabolism, Inborn Errors Amino Acid Metabolism, Inborn Errors Metabolic Disease Phenylketonurias
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 50
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
Rigshospitalet, Denmark · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The overall aim of this study is to evaluate LNAA treatment as a potential alternative to conventional dietary treatment for PKU. This study investigates the effects of LNAA treatment compared to the classic dietary treatment on cerebral dopamine synthesis in patients with classic PKU. We will assess LNAAs effectiveness on neurotransmitter synthesis, cognitive function, mental health, and safety, …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Patients ≥ 18 years of age with Classical PKU molecularly confirmed via the finding of two pathogenic variants in the phenylalanine hydroxylase (PAH) gene and/or historical evidence of Phe concentrations ≥1200 μmol/L in the medical history Inclusion Criteria: * Treatment initiation within the firs…
Contacts

Allan Lund, Professor, MD, DMSc

+4535451303

allan.lund@regionh.dk

CONTACT

Olivia Fjellbirkeland, MD

olivia.welle.fjellbirkeland@regionh.dk

CONTACT